TY - JOUR AU - Brady, R. O. AU - Gal, A. E. AU - Bradley, R. M. AU - Martensson, E. AU - Warshaw, A. L. AU - Laster, L. PY - 1967 DA - 1967// TI - Enzymatic defect in Fabry’s disease: ceramidetrihexosidase deficiency JO - N Engl J Med VL - 276 UR - https://doi.org/10.1056/NEJM196705252762101 DO - 10.1056/NEJM196705252762101 ID - Brady1967 ER - TY - JOUR AU - Nagano, Y. AU - Nakashima, H. AU - Fukuhara, Y. AU - Shimmoto, M. AU - Oshima, A. AU - Ikari, Y. AU - Mori, Y. AU - Sakuraba, H. AU - Suzuki, Y. PY - 1991 DA - 1991// TI - Hypertrophic cardiomyopathy in late-onset variant of Fabry’s disease with high residual activity of alpha-galactosidase A JO - Clin Genet VL - 39 UR - https://doi.org/10.1111/j.1399-0004.1991.tb03018.x DO - 10.1111/j.1399-0004.1991.tb03018.x ID - Nagano1991 ER - TY - JOUR AU - Schiffmann, R. AU - Kopp, J. B. AU - Austin, H. A. AU - Sabnis, S. AU - Moore, D. F. AU - Weibel, T. AU - Balow, J. E. AU - Brady, R. O. PY - 2001 DA - 2001// TI - Enzyme replacement therapy in Fabry disease: A randomized controlled trial JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.21.2743 DO - 10.1001/jama.285.21.2743 ID - Schiffmann2001 ER - TY - JOUR AU - MacDermot, K. D. AU - Holmes, A. AU - Miners, A. H. PY - 2001 DA - 2001// TI - Anderson–Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males JO - J Med Genet VL - 38 UR - https://doi.org/10.1136/jmg.38.11.750 DO - 10.1136/jmg.38.11.750 ID - MacDermot2001 ER - TY - JOUR AU - MacDermot, K. D. AU - Holmes, A. AU - Miners, A. H. PY - 2001 DA - 2001// TI - Anderson–Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females JO - J Med Genet VL - 38 UR - https://doi.org/10.1136/jmg.38.11.769 DO - 10.1136/jmg.38.11.769 ID - MacDermot2001 ER - TY - JOUR AU - Hoffman, G. S. AU - Kerr, G. S. AU - Leavitt, R. Y. AU - Hallahan, C. W. AU - Lebovics, R. S. AU - Travis, W. D. AU - Rottem, M. AU - Fauci, A. S. PY - 1992 DA - 1992// TI - Wegener’s granulomatosis: analysis of 158 patients JO - Ann Intern Med VL - 116 UR - https://doi.org/10.7326/0003-4819-116-6-488 DO - 10.7326/0003-4819-116-6-488 ID - Hoffman1992 ER - TY - JOUR AU - Ntatsaki, E. AU - Watts, R. A. AU - Scott, D. G. PY - 2010 DA - 2010// TI - Epidemiology of ANCA-associated vasculitis JO - Rheum Dis Clin North Am VL - 36 UR - https://doi.org/10.1016/j.rdc.2010.04.002 DO - 10.1016/j.rdc.2010.04.002 ID - Ntatsaki2010 ER - TY - JOUR AU - Watts, R. A. AU - Al-Taiar, A. AU - Scott, D. G. AU - Macgregor, A. J. PY - 2009 DA - 2009// TI - Prevalence and incidence of Wegener’s granulomatosis in the UK general practice research database JO - Arthritis Rheum VL - 61 UR - https://doi.org/10.1002/art.24544 DO - 10.1002/art.24544 ID - Watts2009 ER - TY - JOUR AU - Singh, H. K. AU - Nickeleit, V. AU - Kriegsmann, J. AU - Harris, A. A. AU - Jennette, J. C. AU - Mihatsch, M. J. PY - 2001 DA - 2001// TI - Coexistene of Fabry’s disease and necrotizing and crescentic glomerulonephritis JO - Clin Nephrol VL - 55 ID - Singh2001 ER - TY - JOUR AU - Shimazu, K. AU - Tomiyoshi, Y. AU - Aoki, S. AU - Sakemi, T. AU - Sugihara, H. PY - 2002 DA - 2002// TI - Crescentic glomerulonephritis in a patient with heterozygous Fabry’s disease JO - Nephron VL - 92 UR - https://doi.org/10.1159/000063287 DO - 10.1159/000063287 ID - Shimazu2002 ER - TY - JOUR AU - Hamers, N. M. AU - Donker-Koopman, W. E. AU - Coulon-Morelec, M. J. AU - Dupouey, P. AU - Tager, J. M. PY - 1978 DA - 1978// TI - Characterization of antibodies against ceramide trihexoside and globoside JO - Immunochemistry VL - 15 UR - https://doi.org/10.1016/0161-5890(78)90130-X DO - 10.1016/0161-5890(78)90130-X ID - Hamers1978 ER - TY - JOUR AU - Lin, W. C. AU - Lin, C. F. AU - Chen, C. L. AU - Chen, C. W. AU - Lin, Y. S. PY - 2011 DA - 2011// TI - Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury JO - J Pharmacol Exp Ther VL - 339 UR - https://doi.org/10.1124/jpet.111.181560 DO - 10.1124/jpet.111.181560 ID - Lin2011 ER - TY - JOUR AU - Jennette, J. C. AU - Xiao, H. AU - Falk, R. J. PY - 2006 DA - 2006// TI - Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies JO - J Am Soc Nephrol VL - 5 UR - https://doi.org/10.1681/ASN.2005101048 DO - 10.1681/ASN.2005101048 ID - Jennette2006 ER - TY - JOUR AU - Franssen, C. F. AU - Stegeman, C. A. AU - Kallenberg, C. G. AU - Gans, R. O. AU - De Jong, P. E. AU - Hoorntje, S. J. AU - Tervaert, J. W. PY - 2000 DA - 2000// TI - Antiproteinase 3 and antimyeloperoxidase associated vasculitis JO - Kidney Int VL - 57 UR - https://doi.org/10.1046/j.1523-1755.2000.00080.x DO - 10.1046/j.1523-1755.2000.00080.x ID - Franssen2000 ER - TY - JOUR AU - Van Paassena, P. AU - Tervaerta, J. W. AU - Heeringab, P. PY - 2007 DA - 2007// TI - Mechanisms of vasculitis. how pauci-immune is ANCA-associated renal vasculitis? JO - Nephron Exp Nephrol VL - 105 UR - https://doi.org/10.1159/000096960 DO - 10.1159/000096960 ID - Van Paassena2007 ER - TY - JOUR AU - Nakao, S. AU - Kodama, C. AU - Takenaka, T. AU - Tanaka, A. AU - Yasumoto, Y. AU - Yoshida, A. AU - Kanzaki, T. AU - Enriquez, A. L. AU - Eng, C. M. AU - Tanaka, H. AU - Tei, C. AU - Desnick, R. J. PY - 2003 DA - 2003// TI - Fabry’s disease: Detection of underdiagnosed hemodialysis patients and identification of a "renal variant" phenotype JO - Kidney Int VL - 64 UR - https://doi.org/10.1046/j.1523-1755.2003.00160.x DO - 10.1046/j.1523-1755.2003.00160.x ID - Nakao2003 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/15/157/prepub UR - http://www.biomedcentral.com/1471-2369/15/157/prepub ID - ref17 ER -